Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Asthma · Multiple Sclerosis · TEVA

Teva Pharma

Teva Pharma GmbH

Teva Pharma patent portfolio — 185 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
Status
Public
HQ
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
Employees
126
Programs
7
Drugs
407
Patents
185
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Teva Pharma patents

185 pharmaceutical patents indexed for Teva Pharma. 22 expire within 24 months.

Teva Pharma has 185 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 22 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

185 patents

Patent portfolio

Page 3 of 4

  1. US 7671071

    Polymorphic Form XVI of fexofenadine hydrochloride

    Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7622588

    Method for the purification of lansoprazole

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7619117

    Rasagiline formulations and processes for their preparation

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7605274

    Carvedilol

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7598420

    Rasagiline formulations and processes for their preparation

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7579333

    Therapy using a combination of raloxifene and alendronate

    Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7572641

    Pharmaceutical compositions comprising meloxicam and methods of their preparation

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7572834

    Rasagiline formulations and processes for their preparation

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7569729

    Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7563918

    Solid and crystalline ibandronate sodium and processes for preparation thereof

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7547806

    Tannate salt of rasagiline

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7534913

    Crystalline form of nateglinide

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7514467

    Crystalline solids of carvedilol and processes for their preparation

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7511174

    Solid and crystalline ibandronic acid

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7507861

    Process for the preparation of atomoxetine hydrochloride

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7507829

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7488758

    Levalbuterol hydrochloride polymorph B

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7485663

    Carvedilol

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7482489

    Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

    Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7473780

    Drying process for preparing crystalline solid famciclovir

    Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7465831

    Levalbuterol hydrochloride Polymorph A

    Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7439373

    Crystalline mycophenolate sodium

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7439399

    Processes for the preparation of atomoxetine hydrochloride

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7429374

    Process for the measurement of the potency of glatiramer acetate

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7425644

    Method of purifying pravastatin

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7420084

    Polymorphic forms of nateglinide

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7414140

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7390807

    Crystal forms of lamotrigine and processes for their preparations

    Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7368606

    Amorphous cinacalcet hydrochloride and preparation thereof

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7368468

    Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7357945

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7358247

    Mycophenolate mofetil impurity

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7358390

    Polymorphic forms of nateglinide

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7358360

    Risedronate sodium having a very low content of iron

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7348429

    Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7332612

    Amorphous and crystalline forms of losartan potassium and process for their preparation

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7323459

    Crystal forms, methods for their preparation and method for preparation of olanzapine

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7319171

    Sertraline hydrochloride form II and methods for the preparation thereof

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7262218

    Forms of pravastatin sodium

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7256195

    Preparation of risperidone

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7247751

    Processes for preparing cinacalcet hydrochloride crystal Form I

    Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7235691

    Crystalline forms of modafinil

    Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7196222

    Sertraline hydrochloride form II and methods for the preparation thereof

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7183272

    Crystal forms of oxcarbazepine and processes for their preparation

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Teva Pharma have?

185 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

22 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.